We are live on ! Find out more
TXG icon

10x Genomics
TXG

219 hedge funds and large institutions have $8.54B invested in 10x Genomics in 2020 Q3 according to their latest regulatory filings, with 89 funds opening new positions, 82 increasing their positions, 37 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

456% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 16

327% more call options, than puts

Call options by funds: $32M | Put options by funds: $7.49M

122% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 37

57% more capital invested

Capital invested by funds: $5.45B → $8.54B (+$3.09B)

50% more funds holding

Funds holding: 146 → 219 (+73)

38% more funds holding in top 10

Funds holding in top 10: 8 → 11 (+3)

14.58% less ownership

Funds ownership: 105.34% → 90.76% (-15%)

Holders
219
Holders Change
+73
Holders Change %
+50%
% of All Funds
4.42%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.22%
New
89
Increased
82
Reduced
37
Closed
16
Calls
$32M
Puts
$7.49M
Net Calls
+$24.5M
Net Calls Change
+$6.98M

Top Buyers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
+$260M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$210M
3
BlackRock
BlackRock
New York
+$166M
4
Morgan Stanley
Morgan Stanley
New York
+$156M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$147M

Top Sellers

Rank Fund Capital Flow
1
FCMI
Foresite Capital Management II
California
-$210M
2
SIAU
SB Investment Advisers (UK)
United Kingdom
-$146M
3
VMV
Venrock Management VI
California
-$122M
4
FCMI
Foresite Capital Management I
California
-$78.7M
5
JCM
JS Capital Management
New York
-$47.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCCP
151
Mission Creek Capital Partners
California
$477K +$401K +3,824 New
Aberdeen Group
152
Aberdeen Group
United Kingdom
$477K +$402K +3,825 New
EGM
153
Engineers Gate Manager
New York
$473K +$398K +3,794 New
LPL Financial
154
LPL Financial
California
$439K +$370K +3,524 New
CIBC Asset Management
155
CIBC Asset Management
Ontario, Canada
$438K +$9.13K +87 +3%
FC
156
FORA Capital
Florida
$427K -$237K -2,260 -40%
GA
157
Greenspring Associates
Maryland
$407K +$343K +3,268 New
SEC
158
Seven Eight Capital
New York
$399K +$336K +3,200 New
AWC
159
Abundance Wealth Counselors
Pennsylvania
$393K +$331K +3,149 New
TC
160
TwinBeech Capital
New York
$393K +$331K +3,151 New
GAM
161
Griffin Asset Management
New York
$368K +$310K +2,952 New
AP
162
AlpInvest Partners
Netherlands
$354K +$298K +2,839 New
RWA
163
Ropes Wealth Advisors
Massachusetts
$330K +$278K +2,646 New
URS
164
Utah Retirement Systems
Utah
$312K +$21K +200 +9%
Comerica Bank
165
Comerica Bank
Texas
$303K +$224K +2,133 New
Squarepoint
166
Squarepoint
New York
$293K -$99.1K -944 -29%
IC
167
IEQ Capital
California
$287K +$242K +2,304 New
SM
168
Sciencast Management
New Jersey
$277K +$185K +1,760 New
PCM
169
Prelude Capital Management
New York
$273K +$130K +1,239 +130%
VF
170
Virtu Financial
New York
$271K +$228K +2,173 New
Deutsche Bank
171
Deutsche Bank
Germany
$265K -$18.4M -175,606 -99%
APG
172
Abacus Planning Group
South Carolina
$262K +$220K +2,100 New
VFP
173
Verus Financial Partners
Virginia
$262K +$220K +2,100 New
SC
174
Solstein Capital
California
$261K +$219K +2,090 New
ACM
175
Alpha Capital Management
Texas
$257K +$217K +2,063 New
5 6
7
8 9

TXG Hedge Fund Activity: Q3 2020 in Review

219 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q3 2020, worth a combined $8.54B — up 57% from $5.45B a quarter earlier.

Buyers outnumbered sellers: 89 funds opened new TXG positions and 16 closed out — a net gain of 73 holders — while 82 added to existing stakes and 37 trimmed.

The largest buyer was Fidelity International, opening a new position worth an estimated $260M. The largest seller was Foresite Capital Management II, cutting an estimated $210M.

  • 219 institutional investors held 10x Genomics (TXG) as of Q3 2020, up from 146 in Q2 2020.
  • Funds reported $8.54B of 10x Genomics stock for Q3 2020, up 57% quarter-over-quarter.
  • 89 funds opened new 10x Genomics positions in Q3 2020 and 16 closed out, a net change of +73 holders.
  • The largest 10x Genomics buyer in Q3 2020 was Fidelity International, an estimated $260M added.
  • The largest 10x Genomics seller in Q3 2020 was Foresite Capital Management II, an estimated $210M sold.

Based on aggregated 13F filings for Q3 2020.